Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration
Cardiovascular diseases (CVDs), including atherosclerosis, stroke, and myocardial infarction, is a major cause of death worldwide. In aspects of cell therapy against CVD, it is generally accepted that endothelial progenitor cells (EPCs) are potent neovascular modulators in ischemic tissues. In respo...
Saved in:
Main Authors: | Hyunyun Kim, Sujin Kim, Sang Hong Baek, Sang-Mo Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/8340257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
by: Caterina Oriana Aragona, et al.
Published: (2016-01-01) -
The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization
by: Branislava Janic, et al.
Published: (2010-01-01) -
tPA-MMP-9 Axis Plays a Pivotal Role in Mobilization of Endothelial Progenitor Cells from Bone Marrow to Circulation and Ischemic Region for Angiogenesis
by: Steve Leu, et al.
Published: (2016-01-01) -
Transplanted Endothelial Progenitor Cells Improve Ischemia Muscle Regeneration in Mice by Diffusion Tensor MR Imaging
by: Xin-Gui Peng, et al.
Published: (2016-01-01) -
Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis
by: F. R. Spinelli, et al.
Published: (2013-01-01)